Display options
Share it on

World J Hepatol. 2016 Oct 08;8(28):1182-1193. doi: 10.4254/wjh.v8.i28.1182.

Management of refractory ascites in cirrhosis: Are we out of date?.

World journal of hepatology

Alagappan Annamalai, Lauren Wisdom, Megan Herada, Mazen Nourredin, Walid Ayoub, Vinay Sundaram, Andrew Klein, Nicholas Nissen

Affiliations

  1. Alagappan Annamalai, Lauren Wisdom, Megan Herada, Mazen Nourredin, Walid Ayoub, Vinay Sundaram, Andrew Klein, Nicholas Nissen, Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA 90048, United States.

PMID: 27729954 PMCID: PMC5055587 DOI: 10.4254/wjh.v8.i28.1182

Abstract

Cirrhosis is a major cause of morbidity and mortality worldwide with liver transplantations as it only possible cure. In the face of a significant organ shortage many patients die waiting. A major complication of cirrhosis is the development of portal hypertension and ascites. The management of ascites has barely evolved over the last hundred years and includes only a few milestones in our treatment approach, but has overall significantly improved patient morbidity and survival. Our mainstay to ascites management includes changes in diet, diuretics, shunt procedures, and large volume paracentesis. The understanding of the pathophysiology of cirrhosis and portal hypertension has significantly improved in the last couple of decades but the changes in ascites management have not seemed to mirror this newer knowledge. We herein review the history of ascites management and discuss some its current limitations.

Keywords: Ascites; Cirrhosis; Paracentesis; Portal hypertension; Transhepatic portosystemic shunts

Conflict of interest statement

Conflict-of-interest statement: No potential conflicts of interest. No financial support.

References

  1. J Hepatol. 2010 Sep;53(3):397-417 - PubMed
  2. J Hepatol. 1993;17 Suppl 2:S14-8 - PubMed
  3. Hepatology. 2013 Apr;57(4):1651-3 - PubMed
  4. World J Gastroenterol. 2014 Mar 14;20(10):2704-14 - PubMed
  5. Mol Aspects Med. 2008 Feb-Apr;29(1-2):119-29 - PubMed
  6. Gastroenterology. 2003 Mar;124(3):634-41 - PubMed
  7. Liver Int. 2008 Aug;28(7):1019-25 - PubMed
  8. World J Gastroenterol. 2013 Mar 21;19(11):1707-17 - PubMed
  9. Hepatology. 2004 Sep;40(3):629-35 - PubMed
  10. Gastroenterology. 1990 Dec;99(6):1736-44 - PubMed
  11. Gut. 2001 Mar;48(3):384-9 - PubMed
  12. N Engl J Med. 1967 Mar 2;276(9):491-6 - PubMed
  13. Gastroenterology. 1990 Apr;98(4):1063-70 - PubMed
  14. Dig Liver Dis. 2011 Nov;43(11):881-6 - PubMed
  15. Ann Intern Med. 1992 Aug 1;117(3):215-20 - PubMed
  16. Hepatology. 1987 May-Jun;7(3):423-9 - PubMed
  17. J Hepatol. 1987 Aug;5(1):102-8 - PubMed
  18. Hepatology. 1985 May-Jun;5(3):403-7 - PubMed
  19. Korean J Gastroenterol. 2009 Sep;54(3):143-8 - PubMed
  20. Hepatology. 2003 May;37(5):1147-53 - PubMed
  21. Gastroenterology. 1996 Oct;111(4):1002-10 - PubMed
  22. J Clin Invest. 1948 Jan;27(1):135-44 - PubMed
  23. J Hepatol. 2014 Aug;61(2):396-407 - PubMed
  24. J Cardiovasc Dis Res. 2010 Jul;1(3):136-44 - PubMed
  25. J Hepatol. 1996 Aug;25(2):135-44 - PubMed
  26. Gut. 2002 Jan;50(1):90-4 - PubMed
  27. Gastroenterology. 2002 Dec;123(6):1839-47 - PubMed
  28. Gastroenterology. 1997 Aug;113(2):579-86 - PubMed
  29. Lancet. 1985 Mar 16;1(8429):611-2 - PubMed
  30. Gastroenterology. 2007 Sep;133(3):825-34 - PubMed
  31. Hepatology. 1988 Mar-Apr;8(2):207-10 - PubMed
  32. Am J Gastroenterol. 1989 Mar;84(3):279-84 - PubMed
  33. J Hepatol. 1998 Apr;28(4):639-45 - PubMed
  34. Gastroenterology. 1988 Jun;94(6):1493-502 - PubMed
  35. Hepatology. 1991 Dec;14(6):1025-8 - PubMed
  36. Mediators Inflamm. 2012;2012:318087 - PubMed
  37. Hepatology. 1990 Apr;11(4):662-7 - PubMed
  38. Eur J Intern Med. 2011 Dec;22(6):587-90 - PubMed
  39. N Engl J Med. 2000 Jun 8;342(23):1701-7 - PubMed
  40. Am J Med. 1975 Aug;59(2):165-70 - PubMed
  41. Liver Int. 2014 Aug;34(7):1001-7 - PubMed

Publication Types